HC Wainwright Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $16.00
Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) had its price target hoisted by investment analysts at HC Wainwright from $15.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright also issued estimates for Larimar Therapeutics’ Q1 2025 earnings at ($0.43) EPS, Q2 2025 […]
More Stories
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
The Golden Rule: He Who Has the Gold Makes the Rules
By Rodd Mann “O Gold! I still prefer thee unto paper, which makes bank credit like a bark of vapor.”—Lord...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...
Pipeline Projects Prioritized for Quick Approval Under Emergency Energy Orders
By John Haughey More than 220 natural gas pipeline-related proposals across 22 states are among nearly 700 projects that could...